Concepedia

Sara Harrysson

SH

7

Publications

200

Citations

7

H-Index

2019

Active since

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Lund University

Södra Älvsborg Hospital

University of Gothenburg

Sara Harrysson is an author at Karolinska Institutet specializing in autoimmunity, cellular therapies, and pathology.

ORCID

Top concepts

Publications per year

2019–2022

7

Publications

7

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Sara Harrysson, Sandra Eloranta, Sara Ekberg et al. · Blood Cancer Journal · 2021 · 65 citations · Full text

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients

Sara Harrysson, Sandra Eloranta, Sara Ekberg et al. · British Journal of Haematology · 2022 · 40 citations · Full text

, , +20

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh et al. · Biomedicines · 2020 · 37 citations · Full text

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine L. Lewis, Lasse Jakobsen, Diego Villa et al. · Blood · 2021 · 19 citations

Outcome and determinants of failure to complete primary <scp>R‐CHOP</scp> treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma

Tove Wästerlid, Sara Harrysson, Therése Andersson et al. · American Journal of Hematology · 2020 · 18 citations · Full text

Rows per page

1–5 of 7